Evidence map›Paper›PMID 24993448›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2014

Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Santo Morabito, Valentina Pistolesi, Luigi Tritapepe, Enrico Fiaccadori

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 63 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03976440 unknown statusnot on this mapstarted 2019, after this paper: background citation

Simplified Regional Citrate Anticoagulation Protocols for CVVH, CVVHDF and SLED Focused on the Prevention of RRT-related Hypophosphatemia and Optimization of Acid-base Balance: a Pilot Study

TypeobservationalSponsorUniversity of ParmaRan2019 to 2021Enrolled30ConditionsAcute Renal Failure, Dialysis Related Complication, Hypophosphatemia, HypomagnesemiaArmsRenal Replacement Therapy (RRT) start
NCT04865510 nacompletednot on this mapstarted 2019, after this paper: background citation

Citrate Versus Heparin in Continuous Renal Replacement Therapy : Effect on Cardiovascular System and Clot Circuit in Critically Ill Patients

TypeinterventionalSponsorBangkok Metropolitan Administration Medical College and Vajira HospitalRan2019 to 2021Enrolled41ConditionsAcute Kidney Injury, Citrate, Cytokines, Hemodynamic ResponsesArmsRegional citrate anticoagulation
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 3 syntheses or guidelines pooled it, 164 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. The Application of Regional Citrate Anticoagulation in Protein A Immunoadsorption: A Single-Center Retrospective Cohort Study.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2024
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Santo MorabitoDepartment of Nephrology and Urology, Hemodialysis Unit and santo.morabito@uniroma1.it.
Valentina PistolesiDepartment of Nephrology and Urology, Hemodialysis Unit and.
Luigi TritapepeDepartment of Anesthesiology and Intensive Care, Sapienza University, Rome, Italy; and.
Enrico FiaccadoriDepartment of Clinical and Experimental Medicine, Acute and Chronic Renal Failure Unit, Parma University, Parma, Italy.
Cardialysis (Netherlands) · NLSapienza University of Rome · ITUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemorrhagic complications have been reported in up to 30% of critically ill patients with AKI undergoing RRT with systemic anticoagulation. Because bleeding is associated with significantly increased mortality risk, strategies aimed at reducing hemorrhagic complications while maintaining extracorporeal circulation should be implemented. Among the alternatives to systemic anticoagulation, regional citrate anticoagulation has been shown to prolong circuit life while reducing the incidence of hemorrhagic complications and lowering transfusion needs. For these reasons, the recently published Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Acute Kidney Injury have recommended regional citrate anticoagulation as the preferred anticoagulation modality for continuous RRT in critically ill patients in whom it is not contraindicated. However, the use of regional citrate anticoagulation is still limited because of concerns related to the risk of metabolic complications, the complexity of the proposed protocols, and the need for customized solutions. The introduction of simplified anticoagulation protocols based on citrate and the development of dialysis monitors with integrated infusion systems and dedicated software could lead to the wider use of regional citrate anticoagulation in upcoming years.

Indexed as

Acute Kidney InjuryAnticoagulantsCitratesCritical IllnessDialysis SolutionsHemorrhageHumansHypertonic SolutionsIsotonic SolutionsRegional Blood FlowRenal Replacement TherapyWater-Electrolyte BalanceAnticoagulantsCitratesDialysis SolutionsHypertonic SolutionsIsotonic SolutionsAKIcitrateCRRTregional anticoagulationSLED

Identifiers

PMID24993448
PMCPMC4255392
OpenAlexW2112684338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.